Journal Info

Title: Jurnal Medical Aradean (Arad Medical Journal)
Abbreviated title: J. Med. Ar.
Publisher: "Vasile Goldis" University Press
Owner: Western University "Vasile Goldis" Arad, Romania
ISSN: 1224-3744
e-ISSN: 2067-7790

Ranking and Indexing

Rank: CNCSIS C (code 292) since 2010

International Database: Index Copernicus Journal Master List Value (2010): 4.66

Who's Online

We have 56 guests online

Index Databases

QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT PDF Print E-mail

QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT

This is an automatically generated default intro template - please do not edit.


General information
Title: QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT
Meta keywords:
Meta description:

Images information
Images path absolute: /home/jmedarr/public_html/images/stories/com_form2content/p2/f420
Images path relative: com_form2content/p2/f420
Thumbs path absolute:
Thumbs path relative:

Fields information
Article_Title: QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT
Authors: Adrian Crișan1,3, Horia Dan Mureșanu1,2, Imola Miklos 2, Paul Deme 1, Ioan Ioiart1, 2
Affiliation: 1 Western University ”Vasile Goldiș” Arad
2 Arad County Emergency Hospital Urology Clinic
3 Arad County Emergency Hospital Intensive Care Unit
Abstract: Prostate cancer is one of the most frequent malignancies in the world. Its incidence is in continuous growth especially in developed countries.There isn’t a clear evidence of the patients with prostate cancer in Arad county. The aim of this study is to assess the improving of patients’ qol after they underwent different types of urological palliative treatment. This study is a prospective one and it comprises 71 patients, diagnosed with CRPC who underwent urological palliative treatment.Our results show higher incidence of castrate resistant prostate cancer (CRPC) in patients from urban areas. The main urological palliative treatment applied to the patients was the transurethral resection of the prostate. Our study demonstrates the improving of the quality of life (QoL) after urinary drainage, we found an important improving of the ECOG scor.
Keywords: Qol, CRPC, nephrostomy
References: Alemayehu B, Buysman E, Parry D, Becker L, Nathan F, Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population, J Med Econ 13:351–361, 2010.
Cabrera C, Hirst C, Hayflinger C, Koo L, Co-morbidity among hormone resistant prostate cancer patients in the US. Pharmacoepidemiol Drug Safety 19(A615):S1–S347, 2010.
Damber JE. Castration resistant prostate cancer comprises a heterogeneous group of both symptomatic and asymptomatic patients with or without clinical metastases. Endocrine therapy for prostate cancer. Acta Oncol. 44, 605–609, 2005.
Scher HI, Halabi S, Tannock I, Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J. Clin. Oncol. 26, 1148–1159, 2008.
Read_full_article: pdf/vol19/iss3/4 JMA 2016 - Crisan.pdf
Correspondence: Arad County Emergency Hospital, str. Andrenyi Karolyi nr. 2-4, Arad, Romania
Tel: 0722842370
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Read full article
Article Title: QUALITY OF LIFE ANALYSIS OF PATIENTS WITH CASTRATE RESISTANT PROSTATE CANCER WHO UNDERWENT UROLOGICAL PALLIATIVE TREATMENT
Authors:
Adrian Crișan1,3, Horia Dan Mureșanu1,2, Imola Miklos 2, Paul Deme 1, Ioan Ioiart1, 2
Affiliation: 1 Western University ”Vasile Goldiș” Arad
2 Arad County Emergency Hospital Urology Clinic
3 Arad County Emergency Hospital Intensive Care Unit
Abstract: Prostate cancer is one of the most frequent malignancies in the world. Its incidence is in continuous growth especially in developed countries.There isn’t a clear evidence of the patients with prostate cancer in Arad county. The aim of this study is to assess the improving of patients’ qol after they underwent different types of urological palliative treatment. This study is a prospective one and it comprises 71 patients, diagnosed with CRPC who underwent urological palliative treatment.Our results show higher incidence of castrate resistant prostate cancer (CRPC) in patients from urban areas. The main urological palliative treatment applied to the patients was the transurethral resection of the prostate. Our study demonstrates the improving of the quality of life (QoL) after urinary drainage, we found an important improving of the ECOG scor.
Keywords: Qol, CRPC, nephrostomy
References: Alemayehu B, Buysman E, Parry D, Becker L, Nathan F, Economic burden and healthcare utilization associated with castration-resistant prostate cancer in a commercial and Medicare Advantage US patient population, J Med Econ 13:351–361, 2010.
Cabrera C, Hirst C, Hayflinger C, Koo L, Co-morbidity among hormone resistant prostate cancer patients in the US. Pharmacoepidemiol Drug Safety 19(A615):S1–S347, 2010.
Damber JE. Castration resistant prostate cancer comprises a heterogeneous group of both symptomatic and asymptomatic patients with or without clinical metastases. Endocrine therapy for prostate cancer. Acta Oncol. 44, 605–609, 2005.
Scher HI, Halabi S, Tannock I, Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group. J. Clin. Oncol. 26, 1148–1159, 2008.
*Correspondence: Arad County Emergency Hospital, str. Andrenyi Karolyi nr. 2-4, Arad, Romania
Tel: 0722842370
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it